Clinical Trials Browser

NCT07614061 2026-05-29

Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Phase 1 Recruiting

18 enrolled

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT05546372 2026-05-26

RACCOON

Phase NA Recruiting

122 enrolled

Gastrointestinal

Klatskin Tumor

NCT07030140 2026-05-01

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Phase 2 Recruiting

38 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06125769 2026-04-03

LITALHICA

Phase NA Recruiting

50 enrolled

Gastrointestinal

Klatskin Tumor

NCT05430698 2026-02-09

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

Phase 2 Recruiting

62 enrolled

Gastrointestinal

Klatskin Tumor

NCT07176962 2025-09-16

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Recruiting

1,800 enrolled

Gastrointestinal

Cirrhosis, Familial, with Pulmonary Hypertension, Disease, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT06850753 2025-08-21

SURE-LT

Phase NA Recruiting

15 enrolled

Gastrointestinal

Klatskin Tumor

NCT04993131 2025-07-31

TESLA II

Phase NA Recruiting

15 enrolled

Gastrointestinal

Bile Duct Neoplasms, Klatskin Tumor

NCT06493734 2025-07-15

STRONG II

Phase NA Recruiting

30 enrolled

Gastrointestinal

Klatskin Tumor

NCT06964425 2025-07-02

Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study

Phase NA Recruiting

20 enrolled

Gastrointestinal

Disease, Cholangiocarcinoma, Klatskin Tumor